WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 8201 Infant (under 12 months) mortality rate: 562
GDP / capita (US$): 1'7001 Child (under 5 years) mortality rate: 902

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 14'150  13'724  13'359  13'077  12'889  12'504  10'462  7'289 
Births 446  439  434  429  425  398  387  344 
Surviving infants 429  422  416  411  405  370  364  321 
Pop. less than 5 years 2'042  2'010  1'979  1'950  1'906  1'809  1'775  1'454 
Pop. less than 15 years 5'583  5'493  5'428  5'392  5'310  5'271  4'822  3'567 
Female 15-49 years 3'596  3'446  3'309  3'195  3'149  3'046  2'364  1'531 

Number of reported case

(Click for retrospective incidence data for Zimbabwe)
Diphtheria
Japanese encephalitis
Measles 9'696  853  1'483  13'728  23'650 
Mumps
Pertussis 491  6'290 
Polio* 32 
Rubella 130  20  447  28 
Rubella (CRS) 63 
Tetanus (neonatal) 16  16  134 
Tetanus (total) 28  139 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Zimbabwe)
Vaccine year result method % card seen                                                
BCG 2009  87  DHS   68  95  98  98  100  90  82  74 
DTP1 2009  86  DHS   68  98  99  99  95  87  90 
DTP3 2009  73  DHS   68  95  95  93  89  73  77  78 
HepB_BD          90 
HepB3 2009  73  DHS   68  95  93  89  73  77 
Hib3 2009  73  DHS   68  95  93  89  73 
JapEnc         
MCV 2009  79  DHS   68  93  97  92  90  76  70  76 
MCV2         
PCV1          98  99 
PCV3          95  95 
Pol3 2009  73  DHS   68  95  95  93  89  69  70  78 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  78  EPI   84  75  85  80  60  41  60  43 
PAB         
VAD1          19  95  91  95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Zimbabwe)
BCG 95  98  98  99  90  84  91 
DTP1 98  99  99  95  87  84  96 
DTP3 95  95  93  89  73  78  88 
HepB3 95  95  93  89  73  79 
HepB_BD
Hib3 95  95  93  89  73 
MCV 93  97  92  90  76  75  87 
MCV2
PAB 66  66  66  76  76  76  57 
PCV3 95  21 
Pol3 95  95  93  89  69  78  89 
Rota_last

Number of districts in the country 63  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
97 
   
/
|
|
\
Greater or equal to 90% 71
From 80 to 89% 17
From 50 to 79% 11
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years; +4 weeks; +6 months; No From April 2014
Measles 9 months; Yes
OPV 6, 10, 14 weeks; 18 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes From March 2014
TT 1st contact; +4 weeks; +6 months; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2011-2013  2008-2013  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 63  63  62  63    62  62 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 63  63  62  63  60  62  62 
Nº districts with DTP3 coverage >=80% number 56  55  44  35  27  19  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  87  71  56  45  31  19 
Nº districts with measles (MCV1) coverage >=95% number 35  34  31  21   
% of districts with MCV1 coverage >=95% From 0 to 100% 56  54  50  33  15   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%  

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.